The data shown below were collected from the profiles of 53 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Title |
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19
|
---|---|
Published in |
medRxiv, July 2020
|
DOI | 10.1101/2020.07.20.20157503 |
Pubmed ID | |
Authors |
Garth W. Strohbehn, Brian L. Heiss, Sherin J. Rouhani, Jonathan A. Trujillo, Jovian Yu, Alec J. Kacew, Emily F. Higgs, Jeffrey C. Bloodworth, Alexandra Cabanov, Rachel C. Wright, Adriana K. Koziol, Alexandra Weiss, Keith Danahey, Theodore G. Karrison, Cuoghi C. Edens, Iazsmin Bauer Ventura, Natasha N. Pettit, Bhakti K. Patel, Jennifer Pisano, Mary E. Strek, Thomas F. Gajewski, Mark J. Ratain, Pankti D. Reid |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 7 | 13% |
Mexico | 1 | 2% |
Lebanon | 1 | 2% |
Japan | 1 | 2% |
Unknown | 43 | 81% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 36 | 68% |
Practitioners (doctors, other healthcare professionals) | 12 | 23% |
Scientists | 5 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 71 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 14 | 20% |
Researcher | 8 | 11% |
Student > Master | 7 | 10% |
Other | 6 | 8% |
Student > Ph. D. Student | 5 | 7% |
Other | 15 | 21% |
Unknown | 16 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 32 | 45% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 8% |
Biochemistry, Genetics and Molecular Biology | 5 | 7% |
Nursing and Health Professions | 4 | 6% |
Immunology and Microbiology | 3 | 4% |
Other | 5 | 7% |
Unknown | 16 | 23% |